News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
154 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
Takeda Leaps Into NASH With $470M-Plus Deal With HemoShear Therapeutics
Takeda is jumping into the $40B market for NASH and other diseases of the liver with a $470M+ investment into HemoShear Therapeutics.
October 17, 2017
·
2 min read
·
Alex Keown
Business
Meet the Scientist Who’s Obsessed With Discovering an Exercise Pill That Won’t Give You Cancer
Ronald Evans believes he’s much closer to a fat-burning, muscle-growing drug that won’t, uh, give you cancer.
October 17, 2017
·
1 min read
Drug Development
OncBioMune Preparing to Initiate Trials of Novel Therapeutic Ovarian Cancer Vaccine
OncBioMune has begun the process to initiate clinical studies of OvcaVax for ovarian cancer.
October 17, 2017
·
4 min read
Business
Genmab Announces Net Sales of DARZALEX (Daratumumab) for Third Quarter of 2017
Net sales of DARZALEX in the third quarter of 2017 totaled USD 317 million.
October 17, 2017
·
6 min read
Drug Development
Ignyta Stock Booms on Promising Mid-Stage Lung Cancer Data
The good news led Ignyta’s stock to jump about five percent before settling down.
October 17, 2017
·
3 min read
·
Mark Terry
Business
450 Jobs Eliminated as Novartis Shuts Down Colorado Facility
Novartis is closing its generic-drug manufacturing facility in Broomfield, Colo., which will cut 450 jobs over two years.
October 17, 2017
·
3 min read
·
Mark Terry
Bio NC
Why Intuitive Surgical Should be Worried About Tiny TransEnterix
There’s a new surgical robot in town. Da Vinci, meet Senhance.
October 17, 2017
·
1 min read
Business
Cambridge’s Cydan Scores $34M, Names a New CMO
Cydan snagged $34M to fund its rare disease pipeline and also tapped two new members of its executive leadership team.
October 17, 2017
·
2 min read
·
Alex Keown
Business
AxoGen to Report Third Quarter 2017 Financial Results and Host Conference Call on November 1, 2017
AxoGen management will host an investment-community conference call and webcast following the release at 4:30 p.m. ET.
October 17, 2017
·
4 min read
Biotech Bay
Forty Seven Bags $75M, Bringing in a Total of $150M in Venture Capital
The round was led by new investors as well as existing investors.
October 17, 2017
·
2 min read
·
Mark Terry
1 of 16
Next
